Sagent Pharmaceuticals (SGNT +4%) closed higher today after announcing the launch of its neuromuscular blocking agent vecuronium bromide - which is currently in short supply in the U.S. - for injection in 10 and 20 mg single-use vials.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs